HRH3 and asthma: BP 2–94, one of the earliest explored agonists of H3R, displayed anti-inflammatory and anti-nociceptive properties in mice and was recognized as a promising drug for the treatment of asthma, migraines, related inflammatory diseases, and pain [25], [26].